Related Experiment Video
Updated: May 31, 2026

Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient
Published on: January 7, 2019
Clinical outcomes and plasmid-associated features in KPC-producing Klebsiella pneumoniae bacteraemia
Yu-Chia Hsieh1, Jia-Wen Wu2, Chong-Wei Huang3
1Department of Pediatrics, Chang Gung Children's Hospital, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
Background:
The genetic epidemiology of carbapenem-resistant Klebsiella pneumoniae (CRKP) is geographically distinct. This study aimed to investigate the association of capsular types and plasmid-mediated factors with mortality in patients with CRKP bacteraemia.
Methods:
Patients with CRKP bacteraemia were enrolled at two medical centres between 2017 and 2021. Capsular typing, antimicrobial susceptibility testing, polymerase chain reaction (PCR) for carbapenemase-encoding genes in all strains, and whole-genome sequencing (WGS) of selected strains were performed.
Results:
Among 402 patients with monomicrobial CRKP bacteraemia, 238 (59.2%) strains were carbapenemase-producing. Of the K47 strains (n = 188), 89.9% carried blaKPC; of the K64 (n = 44) strains, 43.2% carried blaKPC or blaOXA-48-like. In a multivariate Cox analysis, blaKPC was a significant predictor of mortality specifically in K64 (aHR = 3.64; p = 0.004) but not in K47. Other carbapenemase genes did not show significant association with their capsular types. WGS identified the 85 selected isolates as ST11 or ST11-1LV; among them, K64-blaKPC(+) strains (n = 11) clustered separately from K64-blaKPC(-) (n = 33) and K47-blaKPC(+) strains (n = 41). Plasmid structure analysis revealed the distinctness of K64-associated blaKPC plasmids which were generally larger than those in K47 and characterized by the presence of a 57-kb region encoding a T4SS module along with Escherichia coli virulence genes traT and traJ. Among 188 KPC-producing K. pneumoniae, independent mortality predictors included Pitt score (aHR = 1.27; p < 0.001), pneumonia (aHR = 1.84; p = 0.01), and ceftazidime-avibactam treatment (aHR = 0.38, p = 0.002). Capsular type was significantly prognostic (p = 0.02), with K47 showing a reduced risk of death (aHR = 0.33; p = 0.009) compared to other types. Additionally, traT was identified as a potential marker for fatal outcomes (aHR = 3.12; p = 0.05).
Conclusions:
Capsular types and the structural characteristics of blaKPC plasmids are associated with clinical outcomes in CRKP bacteraemia. Although traT is a putative marker for high-risk lineages, clinical severity remains the primary predictor of mortality. The capsular type-specific distribution of conjugative plasmids and the co-carriage of traT with blaKPC suggest a potential route for the concurrent dissemination of resistance and lineage-associated genetic features.
More Related Videos
06:05Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Atypical Pneumonia
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Plasmids
Acute Pyelonephritis II: Diagnostic Studies and Management